Skip to content

BioToChina.org

BioToChina.org is the first organization to connect Pharma, Biotech & Medtech BDs in China and the rest of the world.

  • ACCESS ASIA
  • ACCESS ASIA Spring BD Salon & Reception 2026
  • Agenda
  • Register

Tag: Biotech

insight monthly alert

2026 March-雅法全球生物医药交易月报 YAFO Global Biopharma Transactions Report

by biotochina1st April 2026
Continue Reading
Uncategorized

China’s Structural Shift in the Global Innovation

by biotochina23rd March 2026
Continue Reading
Uncategorized

Starpharma to Speak at ACCESS ASIA Partnering Forum | Online Showcase

by biotochina19th September 2025
Continue Reading
Uncategorized

DIFF Biotech to Speak at ACCESS ASIA Partnering Forum | Online Showcase

by biotochina19th September 2025
Continue Reading
Uncategorized

Virion Therapeutics to Speak at ACCESS ASIA Partnering Forum | Online Showcase

by biotochina19th September 202519th September 2025
Continue Reading
Uncategorized

YAFO Client | Breakthrough for Next-Generation TRK Inhibitor: Jiangsu Vcare’s New Anti-tumor Drug, Eratrectinib (VC004) Capsules, Receives NDA Acceptance

by biotochina14th July 2025
Continue Reading

Posts navigation

Older posts

BioToChina.org

BioToChina.org is the first organization to connect Pharma, Biotech & Medtech BDs in China and the rest of the world.

Powered by Tech-Discovery

Blog at WordPress.com.
  • Subscribe Subscribed
    • BioToChina.org
    • Already have a WordPress.com account? Log in now.
    • BioToChina.org
    • Subscribe Subscribed
    • Sign up
    • Log in
    • Report this content
    • View site in Reader
    • Manage subscriptions
    • Collapse this bar
 

Loading Comments...